104 related articles for article (PubMed ID: 6848299)
1. Central effects of beta-adrenoceptor antagonists.
Salem SA; McDevitt DG
Clin Pharmacol Ther; 1983 Jan; 33(1):52-7. PubMed ID: 6848299
[TBL] [Abstract][Full Text] [Related]
2. Central effects of single oral doses of propranolol in man.
Salem SA; McDevitt DG
Br J Clin Pharmacol; 1984 Jan; 17(1):31-6. PubMed ID: 6691887
[TBL] [Abstract][Full Text] [Related]
3. Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.
Currie D; Lewis RV; McDevitt DG; Nicholson AN; Wright NA
Br J Clin Pharmacol; 1988 Aug; 26(2):121-8. PubMed ID: 2905148
[TBL] [Abstract][Full Text] [Related]
4. Effects of atenolol and propranolol on human performance and subjective feelings.
Landauer AA; Pocock DA; Prott FW
Psychopharmacology (Berl); 1979 Jan; 60(2):211-5. PubMed ID: 106432
[TBL] [Abstract][Full Text] [Related]
5. Central effects of repeated administration of atenolol and captopril in healthy volunteers.
McDevitt DG; Currie D; Nicholson AN; Wright NA; Zetlein MB
Eur J Clin Pharmacol; 1994; 46(1):23-8. PubMed ID: 8005182
[TBL] [Abstract][Full Text] [Related]
6. The effects of atenolol (tenormin) and methyldopa on simple tests of central nervous function.
Bayliss PF; Duncan SM
Br J Clin Pharmacol; 1975 Dec; 2(6):527-31. PubMed ID: 9954
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers and psychometric performance: studies in normal volunteers.
McDevitt DG
Eur J Clin Pharmacol; 1985; 28 Suppl():35-8. PubMed ID: 2865148
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined atenolol and nifedipine administration on psychomotor performance in normal subjects.
Gerrard L; Wheeldon NM; McDevitt DG
Eur J Clin Pharmacol; 1995; 48(3-4):229-33. PubMed ID: 7589046
[TBL] [Abstract][Full Text] [Related]
9. Central effects of combined bendrofluazide and atenolol administration. A single dose study in normal subjects.
Gerrard L; Wheeldon NM; McDevitt DG
Eur J Clin Pharmacol; 1993; 45(6):539-43. PubMed ID: 8157039
[TBL] [Abstract][Full Text] [Related]
10. Lipid-soluble and water-soluble beta-blockers. Comparison of the central nervous system depressant effect.
Gengo FM; Huntoon L; McHugh WB
Arch Intern Med; 1987 Jan; 147(1):39-43. PubMed ID: 3541824
[TBL] [Abstract][Full Text] [Related]
11. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
12. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
Pringle TH; McNeill AJ; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
14. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
[TBL] [Abstract][Full Text] [Related]
15. The role of acetaldehyde in human psychomotor function: a double-blind placebo-controlled crossover study.
Kim SW; Bae KY; Shin HY; Kim JM; Shin IS; Youn T; Kim J; Kim JK; Yoon JS
Biol Psychiatry; 2010 May; 67(9):840-5. PubMed ID: 19914598
[TBL] [Abstract][Full Text] [Related]
16. Evidence for cardiac beta 2-adrenoceptors in man.
Brown JE; McLeod AA; Shand DG
Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
[TBL] [Abstract][Full Text] [Related]
17. Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.
Currie D; Lewis RV; McDevitt DG; Nicholson AN; Wright NA
Br J Clin Pharmacol; 1990 Oct; 30(4):527-36. PubMed ID: 2291867
[TBL] [Abstract][Full Text] [Related]
18. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
Hallam KT; Olver JS; McGrath C; Norman TR
Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
[TBL] [Abstract][Full Text] [Related]
19. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.
Barbanoj MJ; García-Gea C; Morte A; Izquierdo I; Pérez I; Jané F
Neuropsychobiology; 2004; 50(4):311-21. PubMed ID: 15539863
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of conventional B-blockers and nebivolol on psychomotor performances in healthy volunteers: a preliminary report.
Kumar A; Khajuria V; Tandon VR; Kapoor B; Singh R
Indian J Physiol Pharmacol; 2007; 51(2):183-8. PubMed ID: 18175665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
